FDA Inspection 694558 — Texas Oncology, P.A. - South Texas Cancer Center
The FDA completed an inspection of Texas Oncology, P.A. - South Texas Cancer Center on October 20, 2010 in Mcallen, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 20, 2010
- Fiscal Year
- 2011
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Mcallen, TX (United States)